Fine	O
-	O
Mapping	O
and	O
Genetic	O
Analysis	O
of	O
the	O
Loci	O
Affecting	O
Hepatic	O
Iron	B-DS
Overload	I-DS
in	O
Mice	B-OG

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
XG	O
FW	O
.	O

Performed	O
the	O
experiments	O
:	O
XG	O
ZZ	O
FZ	O
YT	O
PA	O
QW	O
CW	O
MK	O
.	O

Analyzed	O
the	O
data	O
:	O
XG	O
FW	O
.	O

Contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
:	O
FW	O
.	O

Wrote	O
the	O
paper	O
:	O
XG	O
FW	O
.	O

The	O
liver	O
,	O
as	O
the	O
major	O
organ	O
for	O
iron	O
storage	O
and	O
production	O
of	O
hepcidin	B-GP
,	O
plays	O
pivotal	O
roles	O
in	O
maintaining	O
mammalian	O
iron	O
homeostasis	O
.	O

A	O
previous	O
study	O
showed	O
that	O
Quantitative	O
Trait	O
Loci	O
(	O
QTLs	O
)	O
on	O
chromosome	O
7	O
(	O
Chr7	O
)	O
and	O
16	O
(	O
Chr16	O
)	O
may	O
control	O
hepatic	O
non	O
-	O
heme	O
iron	B-DS
overload	I-DS
in	O
an	O
F2	O
intercross	O
derived	O
from	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
and	O
SWR	B-OG
/	I-OG
J	I-OG
(	I-OG
SWR	I-OG
)	I-OG
mice	I-OG
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
validate	O
the	O
existence	O
of	O
these	O
loci	O
and	O
identify	O
the	O
genes	O
responsible	O
for	O
the	O
phenotypic	O
variations	O
by	O
generating	O
congenic	O
mice	B-OG
carrying	O
SWR	O
chromosome	O
segments	O
expanding	O
these	O
QTLs	O
(	O
D7Mit68	O
-	O
D7Mit71	O
and	O
D16Mit125	O
-	O
D16Mit185	O
,	O
respectively	O
).	O

We	O
excluded	O
involvement	O
of	O
Chr7	O
based	O
on	O
the	O
lack	O
of	O
iron	O
accumulation	O
in	O
congenic	O
mice	B-OG
.	O

In	O
contrast	O
,	O
liver	O
iron	O
accumulation	O
was	O
observed	O
in	O
Chr16	O
congenic	O
mice	B-OG
.	O

Through	O
use	O
of	O
a	O
series	O
of	O
subcongenic	O
murine	O
lines	O
the	O
interval	O
on	O
Chr16	O
was	O
further	O
fine	O
-	O
mapped	O
to	O
a	O
0	O
.	O
8	O
Mb	O
segment	O
spanning	O
11	O
genes	O
.	O

We	O
found	O
that	O
the	O
mRNA	O
expression	O
pattern	O
in	O
the	O
liver	O
remained	O
unchanged	O
for	O
all	O
11	O
genes	O
tested	O
.	O

Most	O
importantly	O
,	O
we	O
detected	O
4	O
missense	O
mutations	O
in	O
3	O
candidate	O
genes	O
including	O
Sidt1	B-GP
(	O
P172R	O
),	O
Spice1	B-GP
(	O
R708S	O
),	O
Boc	B-GP
(	O
Q1051R	O
)	O
and	O
Boc	B-GP
(	O
S450	O
-	O
insertion	O
in	O
B6	O
allele	O
)	O
in	O
the	O
liver	O
of	O
SWR	O
homozygous	O
congenic	O
mice	B-OG
.	O

To	O
further	O
delineate	O
potential	O
modifier	O
gene	O
(	O
s	O
),	O
we	O
reconstituted	O
seven	O
candidate	O
genes	O
,	O
Sidt1	B-GP
,	O
Boc	B-GP
,	O
Zdhhc23	B-GP
,	O
Gramd1c	B-GP
,	O
Atp6v1a	B-GP
,	O
Naa50	B-GP
and	O
Gtpbp8	B-GP
,	O
in	O
mouse	B-OG
liver	O
through	O
hydrodynamic	O
transfection	O
.	O

However	O
,	O
we	O
were	O
unable	O
to	O
detect	O
significant	O
changes	O
in	O
liver	O
iron	O
levels	O
upon	O
reconstitution	O
of	O
these	O
candidate	O
genes	O
.	O

Taken	O
together	O
,	O
our	O
work	O
provides	O
strong	O
genetic	O
evidence	O
of	O
the	O
existence	O
of	O
iron	O
modifiers	O
on	O
Chr16	O
.	O

Moreover	O
,	O
we	O
were	O
able	O
to	O
delineate	O
the	O
phenotypically	O
responsible	O
region	O
to	O
a	O
0	O
.	O
8	O
Mb	O
region	O
containing	O
11	O
coding	O
genes	O
,	O
3	O
of	O
which	O
harbor	O
missense	O
mutations	O
,	O
using	O
a	O
series	O
of	O
congenic	O
mice	B-OG
.	O

Introduction	O

Iron	O
has	O
an	O
essential	O
function	O
in	O
mammalian	O
metabolism	O
[	O
1	O
]	O
as	O
it	O
is	O
a	O
functional	O
component	O
of	O
hemoglobin	B-GP
,	O
myoglobin	B-GP
,	O
cytochromes	B-GP
,	O
and	O
other	O
non	O
-	O
heme	O
enzymes	O
involved	O
in	O
oxygen	O
transport	O
,	O
ATP	O
generation	O
,	O
and	O
detoxification	O
.	O

Free	O
iron	O
is	O
also	O
a	O
potent	O
oxidant	O
that	O
promotes	O
the	O
formation	O
of	O
toxic	O
radicals	O
.	O

Consequently	O
,	O
iron	O
metabolism	O
is	O
tightly	O
regulated	O
through	O
complex	O
regulatory	O
mechanisms	O
at	O
both	O
cellular	O
and	O
systemic	O
levels	O
.	O

Systemic	O
iron	O
balance	O
is	O
accomplished	O
through	O
the	O
regulation	O
of	O
iron	O
absorption	O
in	O
the	O
intestine	O
,	O
recycling	O
in	O
the	O
spleen	O
,	O
and	O
storage	O
in	O
the	O
liver	O
[	O
2	O
].	O

Dysregulation	O
of	O
iron	O
metabolism	O
causes	O
common	O
diseases	O
in	O
mammals	B-OG
that	O
are	O
characterized	O
by	O
iron	O
status	O
;	O
iron	B-DS
-	I-DS
overload	I-DS
is	O
a	O
result	O
of	O
genetic	B-DS
hemochromatosis	I-DS
and	O
iron	O
depletion	O
causes	O
iron	B-DS
-	I-DS
deficiency	I-DS
anemia	I-DS
.	O

The	O
liver	O
is	O
important	O
for	O
systemic	O
iron	O
homeostasis	O
.	O

It	O
is	O
the	O
major	O
organ	O
for	O
iron	O
storage	O
,	O
and	O
iron	O
within	O
the	O
liver	O
can	O
be	O
mobilized	O
to	O
meet	O
the	O
demands	O
of	O
other	O
organs	O
[	O
3	O
].	O

Furthermore	O
,	O
hepcidin	B-GP
,	O
the	O
major	O
iron	O
regulator	O
that	O
controls	O
iron	O
absorption	O
in	O
the	O
intestine	O
,	O
is	O
produced	O
mainly	O
in	O
the	O
liver	O
and	O
secreted	O
into	O
circulation	O
[	O
4	O
].	O

Although	O
many	O
critical	O
discoveries	O
have	O
been	O
made	O
regarding	O
the	O
regulation	O
of	O
iron	O
homeostasis	O
,	O
gaps	O
still	O
exist	O
in	O
our	O
understanding	O
of	O
the	O
details	O
of	O
iron	O
metabolism	O
[	O
5	O
].	O

The	O
clinical	O
course	O
of	O
hemochromatosis	B-DS
is	O
highly	O
variable	O
,	O
indicating	O
that	O
genetic	O
modifiers	O
may	O
contribute	O
to	O
the	O
complexity	O
of	O
this	O
disease	O
[	O
6	O
],	O
and	O
these	O
variations	O
could	O
make	O
individuals	O
more	O
or	O
less	O
susceptible	O
to	O
the	O
pathological	O
processes	O
of	O
iron	B-DS
metabolism	I-DS
disorders	I-DS
.	O

Identification	O
of	O
such	O
genetic	O
modifiers	O
may	O
help	O
us	O
better	O
understand	O
disease	O
pathogenesis	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
detailed	O
molecular	O
control	O
of	O
iron	O
homeostasis	O
.	O

Mice	B-OG
are	O
powerful	O
model	O
organisms	O
for	O
investigating	O
iron	O
-	O
related	O
human	B-OG
genetic	B-DS
diseases	I-DS
[	O
7	O
]	O
as	O
it	O
is	O
possible	O
to	O
perform	O
functional	O
studies	O
on	O
candidate	O
genes	O
under	O
controlled	O
environmental	O
factors	O
with	O
defined	O
genetic	O
crosses	O
.	O

Genome	O
-	O
wide	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
analysis	O
and	O
forward	O
genetic	O
approaches	O
have	O
been	O
successfully	O
used	O
to	O
identify	O
the	O
genetic	O
loci	O
and	O
specific	O
genes	O
that	O
control	O
iron	O
-	O
related	O
quantitative	O
traits	O
such	O
as	O
tissue	O
iron	O
status	O
and	O
red	O
blood	O
cell	O
parameters	O
[	O
8	O
],	O
[	O
9	O
].	O

Previous	O
studies	O
showed	O
marked	O
differences	O
in	O
the	O
concentrations	O
of	O
liver	O
and	O
spleen	O
non	O
-	O
heme	O
iron	O
content	O
among	O
inbred	O
mouse	B-OG
strains	O
[	O
10	O
].	O

C57BL	B-OG
mice	I-OG
have	O
low	O
liver	O
and	O
spleen	O
iron	O
content	O
while	O
SWR	B-OG
/	I-OG
J	I-OG
mice	I-OG
have	O
much	O
higher	O
levels	O
.	O

This	O
difference	O
may	O
partially	O
explain	O
the	O
variance	O
in	O
response	O
to	O
infection	B-DS
and	O
susceptibility	O
to	O
uroporphyria	B-DS
between	O
strains	O
[	O
11	O
].	O

In	O
the	O
past	O
,	O
positional	O
cloning	O
approaches	O
have	O
been	O
successfully	O
used	O
to	O
identify	O
the	O
potent	O
modifiers	O
controlling	O
the	O
variation	O
of	O
iron	O
metabolism	O
between	O
mouse	B-OG
strains	O
[	O
10	O
].	O

Many	O
putative	O
QTLs	O
affecting	O
iron	O
status	O
have	O
been	O
found	O
,	O
however	O
,	O
few	O
have	O
been	O
validated	O
and	O
genes	O
responsible	O
for	O
these	O
traits	O
remain	O
to	O
be	O
identified	O
[	O
12	O
],	O
[	O
13	O
],	O
[	O
14	O
].	O

In	O
a	O
recent	O
study	O
,	O
Grant	O
et	O
al	O
.	O
undertook	O
QTL	O
analysis	O
to	O
examine	O
the	O
genetic	O
basis	O
of	O
variability	O
in	O
liver	O
and	O
spleen	O
iron	O
content	O
between	O
C57BL	O
/	O
6J	O
and	O
SWR	B-OG
mice	I-OG
.	O

The	O
results	O
showed	O
that	O
QTLs	O
on	O
chromosomes	O
2	O
,	O
7	O
,	O
and	O
16	O
control	O
liver	O
non	O
-	O
heme	O
iron	O
content	O
in	O
C57BL	O
/	O
6J	O
×	O
SWR	O
F2	O
male	O
mice	B-OG
[	O
15	O
].	O

For	O
two	O
QTLs	O
,	O
on	O
Chr16	O
and	O
Chr7	O
,	O
the	O
SWR	O
alleles	O
were	O
associated	O
with	O
higher	O
iron	O
levels	O
in	O
male	O
mice	B-OG
.	O

In	O
contrast	O
,	O
for	O
the	O
QTL	O
on	O
Chr2	O
higher	O
iron	O
levels	O
in	O
both	O
liver	O
and	O
spleen	O
were	O
associated	O
with	O
the	O
C57BL	O
/	O
6J	O
allele	O
.	O

However	O
,	O
the	O
modifier	O
genes	O
controlling	O
these	O
QTLs	O
remain	O
to	O
be	O
identified	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
forward	O
genetic	O
approaches	O
to	O
identify	O
the	O
gene	O
(	O
s	O
)	O
accountable	O
for	O
the	O
variability	O
of	O
hepatic	O
iron	O
accumulation	O
based	O
on	O
the	O
previous	O
QTL	O
analysis	O
.	O

Generating	O
a	O
series	O
of	O
congenic	O
mouse	B-OG
models	O
,	O
we	O
validated	O
the	O
previously	O
identified	O
QTL	O
on	O
chromosome	O
16	O
and	O
refined	O
it	O
to	O
an	O
830	O
Kb	O
interval	O
that	O
contains	O
11	O
coding	O
genes	O
.	O

Three	O
genes	O
among	O
these	O
have	O
non	O
-	O
synonymous	O
coding	O
sequence	O
variations	O
,	O
which	O
make	O
them	O
strong	O
candidates	O
for	O
being	O
involved	O
in	O
iron	O
metabolism	O
.	O

Although	O
the	O
in	O
vivo	O
functional	O
test	O
did	O
not	O
identify	O
specific	O
candidates	O
,	O
our	O
work	O
represents	O
progress	O
in	O
positional	O
cloning	O
of	O
the	O
novel	O
iron	O
metabolism	O
modifier	O
present	O
on	O
Chr16	O
in	O
mouse	B-OG
liver	O
.	O

Materials	O
and	O
Methods	O

Mice	B-OG
and	O
diet	O

Mice	B-OG
were	O
fed	O
a	O
standard	O
rodent	O
laboratory	O
diet	O
(	O
232	O
mg	O
iron	O
/	O
kg	O
)	O
from	O
SLRC	O
Laboratory	O
Animal	O
Co	O
.	O

Ltd	O
.	O

All	O
experimental	O
protocols	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
of	O
the	O
Chinese	O
Academy	O
of	O
Sciences	O
[	O
16	O
].	O

For	O
iron	O
-	O
rich	O
diet	O
experiments	O
,	O
8	O
-	O
week	O
-	O
old	O
mice	B-OG
were	O
fed	O
an	O
iron	O
-	O
rich	O
diet	O
(	O
8	O
.	O
3	O
g	O
of	O
carbonyl	O
iron	O
per	O
kg	O
)	O
of	O
egg	O
-	O
white	O
–	O
based	O
AIN	O
-	O
76A	O
-	O
diets	O
(	O
Research	O
Diets	O
,	O
Inc	O
.,	O
New	O
Brunswick	O
,	O
NJ	O
)	O
for	O
1	O
week	O
before	O
sacrificing	O
.	O

Development	O
and	O
analysis	O
of	O
chromosome	O
16	O
and	O
7	O
congenic	O
mice	B-OG

The	O
B6	O
×	O
SWR	O
F1	O
progeny	O
were	O
backcrossed	O
to	O
B6	O
to	O
get	O
N2	O
progeny	O
that	O
harbor	O
different	O
SWR	O
genomic	O
regions	O
.	O

Congenic	O
strains	O
were	O
then	O
developed	O
by	O
continuous	O
backcrossing	O
of	O
N2	O
progeny	O
to	O
B6	B-OG
mice	I-OG
with	O
MIT	O
SSLP	O
markers	O
-	O
assisted	O
tracing	O
of	O
the	O
SWR	O
chromosome	O
16	O
segment	O
of	O
interest	O
.	O

During	O
backcrossing	O
,	O
we	O
selected	O
mice	B-OG
containing	O
20	O
Mb	O
of	O
SWR	O
on	O
chromosome	O
16	O
between	O
markers	O
D16Mit125	O
-	O
D16Mit185	O
.	O

After	O
backcrossing	O
with	O
C57BL	O
/	O
6J	O
for	O
five	O
generations	O
,	O
we	O
consider	O
the	O
congenic	O
mice	B-OG
to	O
have	O
a	O
pure	O
C57BL	O
/	O
6J	O
background	O
and	O
backcrossing	O
continued	O
(	O
N	O
≥	O
9	O
)	O
[	O
10	O
].	O

The	O
heterozygous	O
mice	B-OG
of	O
the	O
initial	O
Line1	O
were	O
backcrossed	O
to	O
B6	O
to	O
generate	O
subcongenic	O
lines	O
.	O

The	O
original	O
chromosome	O
7	O
congenic	O
line	O
was	O
developed	O
using	O
the	O
same	O
crossing	O
strategy	O
by	O
tracing	O
the	O
SWR	O
chromosome	O
7	O
segment	O
between	O
D7Mit68	O
and	O
D7Mit71	O
.	O

All	O
iron	O
phenotype	O
analyses	O
were	O
performed	O
using	O
8	O
-	O
week	O
-	O
old	O
males	O
unless	O
otherwise	O
indicated	O
.	O

Genotyping	O
primers	O
are	O
listed	O
in	O
Table	O
S1	O
.	O

Genomic	O
DNA	O
sequence	O
analysis	O

DNA	O
segments	O
of	O
every	O
exon	O
and	O
intron	O
-	O
exon	O
boundary	O
of	O
the	O
candidate	O
genes	O
were	O
amplified	O
using	O
PCR	O
and	O
the	O
sequences	O
were	O
aligned	O
in	O
comparison	O
with	O
B6	O
using	O
Lasergene	O
software	O
(	O
DNASTAR	O
).	O

All	O
sequencing	O
data	O
has	O
been	O
deposited	O
in	O
GenBank	O
and	O
the	O
Accession	O
numbers	O
are	O
listed	O
in	O
Table	O
1	O
.	O

Summary	O
of	O
genomic	O
DNA	O
sequencing	O
results	O
in	O
the	O
candidate	O
interval	O
.	O

Gene	O

Accession	O
number	O

Polymorphism	O

Position	O
in	O
gene	O

Protein	O
Variation	O

Sidt1	B-GP

rs4179590	O

G	O
/	O
A	O

Exon3	O

rs4179589	O

G	O
/	O
C	O

Exon3	O

P172R	O

rs51960690	O

G	O
/	O
A	O

Exon10	O

rs50972129	O

A	O
/	O
G	O

Exon10	O

rs4179517	O

A	O
/	O
G	O

Intron11	O
–	O
12	O

rs4179515	O

G	O
/	O
A	O

Exon12	O

rs48139623	O

A	O
/	O
G	O

Intron14	O
–	O
15	O

rs32704753	O

G	O
/	O
A	O

Exon16	O

rs4179510	O

T	O
/	O
C	O

Exon16	O

rs4179504	O

A	O
/	O
G	O

Exon18	O

Spice1	B-GP

rs4179702	O

C	O
/	O
A	O

Exon14	O

R708S	O

rs31418354	O

T	O
/	O
C	O

Exon14	O

Boc	B-GP

NW_001030584	O
.	O
1	O

CGT	O
insertion	O

Exon8	O

S450	O
-	O
insertion	O

rs4179917	O

C	O
/	O
A	O

Intron11	O
–	O
12	O

rs4179913	O

C	O
/	O
T	O

Exon16	O

rs45694900	O

A	O
/	O
G	O

Exon16	O

rs4179908	O

T	O
/	O
C	O

Exon19	O

Q1051R	O

rs4179907	O

G	O
/	O
A	O

3	O
′	O
UTR	O

Wdr52	O

rs4179728	O

A	O
/	O
G	O

Exon3	O

rs4179729	O

T	O
/	O
C	O

Exon3	O

rs4179745	O

T	O
/	O
C	O

Intron10	O
–	O
11	O

ENSMUSSNP328538	O

C	O
/	O
A	O

Intron14	O
–	O
15	O

rs32712110	O

T	O
/	O
C	O

Exon17	O

rs4179843	O

C	O
/	O
T	O

Intron26	O
–	O
27	O

rs4179872	O

T	O
/	O
C	O

Exon28	O

rs31418356	O

C	O
/	O
T	O

Intron28	O
–	O
29	O

rs32712642	O

C	O
/	O
T	O

Exon31	O

Measurements	O
of	O
tissue	O
non	O
-	O
heme	O
iron	O
,	O
heme	O
,	O
and	O
serum	O
iron	O

Quantitative	O
measurement	O
of	O
tissue	O
non	O
-	O
heme	O
iron	O
and	O
serum	O
iron	O
parameters	O
were	O
performed	O
as	O
previously	O
described	O
[	O
17	O
].	O

Heme	O
content	O
was	O
measured	O
using	O
QuantiChrom	O
™	O
Heme	O
Assay	O
Kit	O
(	O
BioAssay	O
Systems	O
,	O
DIHM	O
-	O
250	O
)	O
according	O
to	O
the	O
manual	O
and	O
was	O
normalized	O
using	O
protein	O
concentrations	O
.	O

Quantitative	O
RT	O
-	O
PCR	O

Quantitative	O
RT	O
-	O
PCR	O
(	O
qPCR	O
)	O
was	O
performed	O
as	O
described	O
previously	O
[	O
16	O
].	O

Raw	O
data	O
was	O
normalized	O
to	O
internal	O
β	B-GP
-	I-GP
actin	I-GP
and	O
presented	O
as	O
relative	O
expression	O
levels	O
.	O

All	O
primers	O
for	O
qPCR	O
are	O
described	O
in	O
Table	O
S2	O
.	O

Western	O
blots	O

Western	O
blots	O
were	O
performed	O
as	O
previously	O
described	O
[	O
16	O
].	O

Primary	O
antibodies	B-GP
used	O
are	O
as	O
follows	O
:	O
rabbit	B-OG
anti	O
-	O
H	B-GP
-	I-GP
ferritin	I-GP
(	O
1	O
∶	O
1000	O
dilution	O
,	O
Alpha	O
Diagnostics	O
International	O
),	O
rabbit	B-OG
anti	O
-	O
L	B-GP
-	I-GP
ferritin	I-GP
(	O
1	O
∶	O
1000	O
dilution	O
,	O
ABCAM	O
),	O
rabbit	B-OG
anti	O
-	O
flag	O
(	O
1	O
∶	O
1000	O
dilution	O
,	O
cell	O
signaling	O
),	O
rabbit	B-OG
anti	O
-	O
Sidt1	B-GP
(	O
1	O
∶	O
1000	O
dilution	O
,	O
Santa	O
Cruz	O
),	O
rabbit	B-OG
anti	O
-	O
β	B-GP
-	I-GP
actin	I-GP
(	O
1	O
∶	O
2000	O
dilution	O
,	O
Sigma	O
),	O
rabbit	B-OG
anti	O
-	O
mouse	B-OG
ferroportin	B-GP
(	O
1	O
∶	O
1000	O
).	O
Quantification	O
of	O
western	O
blots	O
was	O
performed	O
using	O
Quantity	O
One	O
(	O
Bio	O
-	O
Rad	O
)	O
according	O
to	O
the	O
manual	O
.	O

Constructs	O
and	O
plasmids	O

Full	O
-	O
length	O
mouse	B-OG
cDNA	O
of	O
candidates	O
including	O
Zdhhc23	B-GP
,	O
Gramd1c	B-GP
,	O
Atp6v1a	B-GP
,	O
Naa50	B-GP
,	O
Sidt1	B-GP
,	O
Boc	B-GP
and	O
Gtpbp8	B-GP
were	O
obtained	O
from	O
Open	O
Biosystems	O
.	O

We	O
first	O
cloned	O
each	O
gene	O
'	O
s	O
CDS	O
into	O
pCMV	O
-	O
3Tag	O
-	O
3A	O
(	O
Agilent	O
Technologies	O
)	O
with	O
a	O
C	O
-	O
terminally	O
expressed	O
3	O
×	O
Flag	O
tag	O
.	O

The	O
3	O
×	O
flag	O
fusion	O
proteins	O
were	O
then	O
subcloned	O
into	O
the	O
final	O
pLive	O
Vector	O
(	O
Mirus	O
,	O
Madison	O
,	O
WI	O
)	O
for	O
Hydrodynamic	O
-	O
based	O
transfection	O
.	O

For	O
cell	O
-	O
based	O
iron	O
uptake	O
assays	O
,	O
CDS	O
of	O
mSidt1	B-GP
(	O
B6	O
and	O
SWR	O
allele	O
)	O
was	O
cloned	O
into	O
pCMV	O
-	O
Sport6	O
(	O
Open	O
Biosystems	O
).	O

Mutagenesis	O
:	O
The	O
pCMV	O
-	O
Sidt1	B-GP
-	O
SWR	O
clone	O
containing	O
the	O
P172R	O
mutation	O
was	O
constructed	O
using	O
the	O
QuikChange	O
®	O
II	O
Site	O
-	O
Directed	O
Mutagenesis	O
Kit	O
(	O
Stratagene	O
)	O
following	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Hydrodynamic	O
-	O
based	O
transfection	O
in	O
vivo	O

The	O
pLive	O
Vector	O
designed	O
for	O
prolonged	O
expression	O
of	O
transgenes	O
in	O
mouse	B-OG
liver	O
was	O
purchased	O
from	O
Mirus	O
(	O
Madison	O
,	O
WI	O
).	O

All	O
plasmid	O
DNAs	O
were	O
purified	O
with	O
the	O
Endofree	O
Plasmid	O
Maxi	O
Kit	O
(	O
Qiagen	O
).	O

A	O
total	O
of	O
30	O
ug	O
purified	O
plasmid	O
DNA	O
was	O
delivered	O
into	O
the	O
livers	O
of	O
6	O
-	O
week	O
-	O
old	O
C57BL	B-OG
/	I-OG
6J	I-OG
male	I-OG
mice	I-OG
by	O
hydrodynamic	O
tail	O
vein	O
injection	O
of	O
the	O
plasmid	O
in	O
a	O
10	O
%	O
body	O
volume	O
of	O
saline	O
.	O

Measurement	O
of	O
iron	O
uptake	O

HEK	O
293T	O
cells	O
were	O
transiently	O
transfected	O
with	O
mSidt1	B-GP
(	O
B6	O
and	O
SWR	O
allele	O
),	O
mZip14	B-GP
[	O
18	O
],	O
or	O
an	O
empty	O
vector	O
for	O
48	O
h	O
(	O
Fugene	O
HD	O
,	O
Roche	O
).	O

Prior	O
to	O
uptake	O
,	O
cells	O
were	O
washed	O
twice	O
with	O
serum	O
-	O
free	O
medium	O
(	O
SFM	O
)	O
and	O
incubated	O
at	O
37	O
°	O
C	O
for	O
1	O
h	O
in	O
SFM	O
containing	O
2	O
%	O
BSA	O
to	O
deplete	O
cells	O
of	O
transferrin	B-GP
and	O
to	O
block	O
nonspecific	O
binding	O
.	O

The	O
uptake	O
buffer	O
(	O
130	O
mM	O
NaCl	O
,	O
10	O
mM	O
KCl	O
,	O
1	O
mM	O
CaCl2	O
and	O
1	O
mM	O
MgSO4	O
)	O
was	O
adjusted	O
to	O
the	O
indicated	O
pH	O
value	O
(	O
7	O
.	O
5	O
,	O
6	O
.	O
5	O
,	O
and	O
5	O
.	O
5	O
)	O
using	O
HEPES	O
buffers	O
[	O
19	O
],	O
[	O
20	O
].	O

For	O
uptake	O
,	O
cells	O
were	O
incubated	O
with	O
2	O
µM	O
59Fe	O
-	O
ferric	O
citrate	O
in	O
SFM	O
in	O
the	O
presence	O
of	O
1	O
mM	O
L	O
-	O
ascorbic	O
acid	O
for	O
2	O
h	O
at	O
37	O
°	O
C	O
,	O
followed	O
by	O
washing	O
three	O
times	O
with	O
iron	O
chelator	O
solution	O
(	O
1	O
mM	O
bathophenanthroline	O
sulfonate	O
and	O
1	O
m	O
M	O
diethylenetriaminepenta	O
acetic	O
acid	O
)	O
to	O
remove	O
any	O
surface	O
-	O
bound	O
iron	O
.	O

Cells	O
were	O
lysed	O
in	O
buffer	O
containing	O
0	O
.	O
2	O
N	O
NaOH	O
and	O
0	O
.	O
2	O
%	O
SDS	O
.	O

Radioactivity	O
was	O
determined	O
by	O
gamma	O
counting	O
,	O
and	O
protein	O
concentration	O
was	O
determined	O
colorimetrically	O
by	O
using	O
the	O
RC	O
DC	O
protein	O
assay	O
(	O
Bio	O
-	O
Rad	O
).	O

Three	O
independent	O
assays	O
were	O
performed	O
in	O
triplicate	O
.	O

Statistical	O
analysis	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

All	O
experiments	O
were	O
performed	O
in	O
triplicate	O
.	O

Student	O
'	O
s	O
t	O
-	O
test	O
was	O
used	O
for	O
comparison	O
between	O
two	O
groups	O
(	O
unpaired	O
,	O
2	O
-	O
tailed	O
).	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
.	O

Results	O

Validation	O
that	O
the	O
QTL	O
on	O
Chromosome	O
16	O
affects	O
basal	O
liver	O
non	O
-	O
heme	O
iron	O
content	O

A	O
previous	O
linkage	O
analysis	O
by	O
Grant	O
et	O
al	O
.	O
identified	O
two	O
QTLs	O
,	O
one	O
on	O
Chr7	O
and	O
one	O
on	O
Chr16	O
,	O
affecting	O
basal	O
non	O
-	O
heme	O
iron	O
content	O
in	O
murine	O
liver	O
[	O
21	O
].	O

The	O
microsatellite	O
markers	O
nearest	O
the	O
calculated	O
peak	O
of	O
the	O
QTLs	O
were	O
identified	O
as	O
D7Mit71	O
and	O
D16Mit30	O
.	O

To	O
extend	O
on	O
this	O
study	O
,	O
congenic	O
mice	B-OG
were	O
created	O
for	O
Chr7	O
and	O
Chr16	O
by	O
producing	O
F1	O
hybrids	O
between	O
C57BL	O
/	O
6J	O
and	O
SWR	O
,	O
followed	O
by	O
at	O
least	O
nine	O
successive	O
backcrosses	O
to	O
the	O
C57BL	O
/	O
6J	O
parental	O
strain	O
.	O

The	O
genome	O
interval	O
transferred	O
in	O
the	O
original	O
congenic	O
lines	O
spanned	O
from	O
D7Mit68	O
to	O
D7Mit71	O
and	O
from	O
D16Mit125	O
to	O
D16Mit185	O
(	O
Figure	O
1A	O
).	O

The	O
regions	O
extended	O
beyond	O
the	O
confidence	O
interval	O
to	O
ensure	O
that	O
all	O
the	O
genetic	O
factors	O
that	O
could	O
contribute	O
to	O
the	O
QTL	O
-	O
associated	O
phenotype	O
would	O
be	O
transferred	O
to	O
the	O
resulting	O
congenics	O
.	O

Haplotypes	O
and	O
quantitative	O
measurements	O
of	O
tissue	O
iron	O
in	O
original	O
congenic	O
strains	O
of	O
chromosome	O
16	O
and	O
7	O
.	O

(	O
A	O
)	O
Schematic	O
of	O
original	O
congenic	O
lines	O
carrying	O
portions	O
of	O
SWR	O
chromosomes	O
7	O
and	O
16	O
(	O
black	O
)	O
on	O
a	O
B6	O
(	O
grey	O
)	O
background	O
.	O

(	O
B	O
)	O
Liver	O
and	O
spleen	O
non	O
-	O
heme	O
iron	O
concentrations	O
of	O
Chr16	O
Line	O
1	O
.	O

(	O
C	O
)	O
Liver	O
and	O
spleen	O
non	O
-	O
heme	O
iron	O
concentrations	O
of	O
congenic	O
lines	O
of	O
Chr7	O
Line	O
1	O
.	O

(	O
D	O
)	O
Serum	O
iron	O
,	O
unsaturated	O
iron	O
binding	O
capacity	O
(	O
UIBC	O
)	O
and	O
total	O
iron	O
binding	O
capacity	O
(	O
TIBC	O
),	O
and	O
(	O
E	O
)	O
Serum	O
transferrin	B-GP
saturations	O
(	O
Tf	B-GP
%)	O
measurement	O
of	O
Chr16	O
Line	O
1	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
.	O

N	O
.	O
S	O
:	O
no	O
significance	O
,	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
.	O
n	O
>	O
5	O
for	O
each	O
group	O
.	O

We	O
used	O
an	O
intercross	O
strategy	O
to	O
determine	O
the	O
iron	O
phenotype	O
of	O
the	O
SWR	O
homozygous	O
(	O
s	O
/	O
s	O
)	O
progeny	O
of	O
each	O
congenic	O
mouse	B-OG
at	O
the	O
age	O
of	O
8	O
weeks	O
.	O

The	O
Chr16s	O
/	O
s	O
congenics	O
containing	O
the	O
SWR	O
haplotype	O
between	O
D16Mit125	O
to	O
D16Mit30	O
showed	O
significantly	O
higher	O
liver	O
non	O
-	O
heme	O
iron	O
content	O
compared	O
with	O
Chr16b	O
/	O
b	O
controls	O
,	O
indicating	O
that	O
the	O
previously	O
detected	O
QTL	O
fell	O
in	O
this	O
region	O
(	O
Figure	O
1B	O
).	O

In	O
contrast	O
,	O
the	O
Chr7s	O
/	O
s	O
congenics	O
containing	O
the	O
chromosome	O
7	O
segments	O
did	O
not	O
show	O
significant	O
differences	O
in	O
liver	O
non	O
-	O
heme	O
iron	O
content	O
compared	O
with	O
the	O
Chr7b	O
/	O
b	O
controls	O
(	O
Figure	O
1C	O
).	O

Moreover	O
,	O
Chr16s	O
/	O
s	O
congenics	O
also	O
showed	O
significantly	O
higher	O
serum	O
iron	O
levels	O
and	O
transferrin	B-GP
(	O
Tf	B-GP
)-	O
saturation	O
levels	O
compared	O
with	O
Chr16b	O
/	O
b	O
controls	O
(	O
Figure	O
1D	O
,	O
1E	O
).	O

No	O
significant	O
changes	O
in	O
iron	O
non	O
-	O
heme	O
content	O
of	O
spleen	O
or	O
other	O
major	O
organs	O
(	O
Figure	O
S1	O
)	O
were	O
found	O
in	O
Chr16	O
congenics	O
.	O

Thus	O
,	O
we	O
chose	O
the	O
Chr16	O
congenic	O
line	O
for	O
further	O
study	O
.	O

Fine	O
mapping	O
of	O
the	O
QTL	O
on	O
Chromosome	O
16	O
with	O
congenic	O
mice	B-OG

To	O
fine	O
-	O
map	O
the	O
QTL	O
on	O
Chr16	O
,	O
we	O
continuously	O
backcrossed	O
the	O
initial	O
Chr16	O
congenic	O
line	O
1	O
with	O
B6	B-OG
mice	I-OG
to	O
generate	O
subcongenic	O
lines	O
carrying	O
various	O
SWR	O
chromosome	O
segments	O
between	O
D16Mit125	O
and	O
D16Mit185	O
(	O
Figure	O
2A	O
).	O

Six	O
subcongenic	O
lines	O
were	O
developed	O
successfully	O
.	O

We	O
then	O
examined	O
the	O
iron	O
phenotype	O
of	O
these	O
lines	O
.	O

Out	O
of	O
the	O
six	O
congenic	O
lines	O
,	O
three	O
lines	O
of	O
s	O
/	O
s	O
homozygous	O
(	O
Chr16	O
line	O
2	O
,	O
line	O
3	O
,	O
and	O
line	O
4	O
)	O
showed	O
significant	O
increases	O
in	O
liver	O
non	O
-	O
heme	O
iron	O
content	O
,	O
which	O
were	O
consistent	O
with	O
the	O
original	O
line	O
1	O
(	O
Figure	O
2B	O
,	O
2C	O
,	O
2D	O
).	O

In	O
contrast	O
,	O
the	O
other	O
three	O
lines	O
of	O
s	O
/	O
s	O
homozygous	O
mice	B-OG
(	O
Chr16	O
line	O
5	O
,	O
line	O
6	O
,	O
and	O
line	O
7	O
)	O
did	O
not	O
show	O
such	O
differences	O
(	O
Figure	O
S2A	O
,	O
S2B	O
,	O
S2C	O
).	O

Haplotypes	O
and	O
iron	O
phenotype	O
analysis	O
of	O
subcongenic	O
lines	O
of	O
Chr16	O
.	O

(	O
A	O
)	O
Map	O
of	O
subcongenic	O
lines	O
derived	O
from	O
the	O
original	O
line	O
.	O

(	O
B	O
–	O
D	O
)	O
Measurement	O
of	O
liver	O
and	O
spleen	O
non	O
-	O
heme	O
iron	O
of	O
congenic	O
Line	O
2	O
,	O
Line	O
3	O
,	O
and	O
Line	O
4	O
(	O
n	O
>	O
5	O
per	O
group	O
).	O

(	O
E	O
)	O
Serum	O
iron	O
,	O
unsaturated	O
iron	O
binding	O
capacity	O
(	O
UIBC	O
),	O
and	O
total	O
iron	O
binding	O
capacity	O
(	O
TIBC	O
),	O
and	O
(	O
F	O
)	O
Serum	O
transferrin	B-GP
saturation	O
(	O
Tf	B-GP
%)	O
measurement	O
of	O
congenic	O
Line	O
3	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
.	O

Congenic	O
line	O
3	O
contained	O
the	O
smallest	O
critical	O
region	O
spanning	O
from	O
D16Mit379	O
to	O
D16Mf1	O
,	O
and	O
thus	O
,	O
was	O
used	O
for	O
further	O
study	O
.	O

The	O
s	O
/	O
s	O
homozygous	O
of	O
line	O
3	O
also	O
showed	O
significantly	O
higher	O
serum	O
iron	O
and	O
transferrin	B-GP
saturation	O
levels	O
compared	O
with	O
b	O
/	O
b	O
homozygous	O
controls	O
(	O
Figure	O
2E	O
,	O
2F	O
).	O

Expression	O
profile	O
of	O
iron	O
-	O
related	O
genes	O
in	O
congenic	O
mice	B-OG

The	O
candidate	O
gene	O
(	O
s	O
)	O
underlying	O
this	O
QTL	O
may	O
affect	O
iron	O
homeostasis	O
through	O
modification	O
of	O
known	O
iron	O
-	O
regulatory	O
pathway	O
(	O
s	O
)	O
and	O
iron	O
-	O
related	O
genes	O
.	O

Thus	O
,	O
we	O
examined	O
the	O
expression	O
of	O
some	O
iron	O
-	O
related	O
genes	O
in	O
the	O
liver	O
and	O
intestine	O
of	O
congenic	O
mice	B-OG
.	O

Consistent	O
with	O
higher	O
hepatic	O
non	O
-	O
heme	O
iron	O
content	O
,	O
the	O
ferritin	B-GP
protein	O
levels	O
,	O
an	O
indicator	O
of	O
intracellular	O
iron	O
levels	O
,	O
were	O
significantly	O
higher	O
in	O
the	O
s	O
/	O
s	O
homozygous	O
mice	B-OG
compared	O
with	O
the	O
b	O
/	O
b	O
homozygous	O
controls	O
(	O
Figure	O
3A	O
).	O

Expression	O
profile	O
of	O
selected	O
iron	O
-	O
related	O
genes	O
in	O
congenic	O
liver	O
and	O
duodenum	O
.	O

Ferritin	B-GP
-	I-GP
L	I-GP
protein	O
expression	O
in	O
liver	O
(	O
A	O
)	O
and	O
ferroportin1	B-GP
and	O
ferritin	B-GP
-	I-GP
H	I-GP
expression	O
in	O
duodenum	O
(	O
C	O
)	O
of	O
Chr16b	O
/	O
b	O
and	O
Chr16s	O
/	O
s	O
mice	B-OG
were	O
assessed	O
by	O
western	O
blot	O
.	O

Quantification	O
of	O
protein	O
levels	O
normalized	O
to	O
actin	B-GP
was	O
performed	O
using	O
densitometry	O
in	O
three	O
independent	O
experiments	O
.	O

Relative	O
mRNA	O
levels	O
of	O
selected	O
iron	O
-	O
related	O
genes	O
were	O
measured	O
by	O
qRT	O
-	O
PCR	O
in	O
liver	O
(	O
B	O
)	O
and	O
duodenum	O
(	O
D	O
)	O
of	O
Chr16	O
congenics	O
and	O
are	O
represented	O
as	O
ratios	O
normalized	O
to	O
Chr16b	O
/	O
b	O
,	O
which	O
was	O
defined	O
as	O
1	O
.	O
0	O
.	O
n	O
>	O
=	O
5	O
for	O
each	O
group	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
.	O

The	O
qPCR	O
results	O
showed	O
a	O
1	O
.	O
7	O
-	O
fold	O
upregulation	O
in	O
the	O
expression	O
of	O
the	O
iron	O
-	O
related	O
gene	O
,	O
Hmox1	B-GP
,	O
in	O
Chr16s	O
/	O
s	O
congenic	O
livers	O
compared	O
with	O
Chr16b	O
/	O
b	O
control	O
livers	O
,	O
which	O
was	O
consistent	O
with	O
the	O
hepatic	O
iron	O
accumulation	O
(	O
Figure	O
3B	O
).	O

Complex	O
regulatory	O
mechanisms	O
control	O
the	O
expression	O
of	O
Hmox1	B-GP
;	O
this	O
protein	O
can	O
be	O
induced	O
by	O
iron	O
,	O
oxidative	O
stress	O
and	O
inflammatory	O
stimuli	O
.	O

In	O
addition	O
,	O
Hmox1	B-GP
can	O
be	O
regulated	O
by	O
cellular	O
heme	O
level	O
through	O
the	O
transcription	B-GP
factor	I-GP
Bach1	B-GP
[	O
22	O
],	O
[	O
23	O
].	O

We	O
found	O
significant	O
increases	O
in	O
heme	O
content	O
and	O
the	O
expression	O
of	O
Fth1	B-GP
,	O
another	O
downstream	O
target	O
of	O
Bach1	B-GP
,	O
in	O
Chr16s	O
/	O
s	O
congenic	O
livers	O
compared	O
with	O
Chr16b	O
/	O
b	O
controls	O
.	O

We	O
also	O
detected	O
a	O
significant	O
increase	O
in	O
expression	O
of	O
Sod1	B-GP
and	O
Gpx4	B-GP
,	O
which	O
are	O
involved	O
in	O
the	O
anti	O
-	O
oxidant	O
response	O
(	O
Figure	O
S3A	O
,	O
S3B	O
).	O

In	O
contrast	O
,	O
we	O
found	O
no	O
significant	O
changes	O
in	O
mRNA	O
levels	O
of	O
pro	B-GP
-	I-GP
inflammatory	I-GP
cytokines	I-GP
including	O
IL	B-GP
-	I-GP
6	I-GP
,	O
TNF	B-GP
-	I-GP
α	I-GP
,	O
or	O
IL	B-GP
-	I-GP
1β	I-GP
in	O
Chr16s	O
/	O
s	O
congenic	O
liver	O
or	O
spleen	O
(	O
Figure	O
S3C	O
)	O
indicating	O
that	O
the	O
inflammatory	O
status	O
in	O
our	O
models	O
is	O
normal	O
.	O

Taken	O
together	O
,	O
we	O
found	O
a	O
significant	O
increase	O
in	O
heme	O
content	O
and	O
oxidative	O
stress	O
level	O
as	O
indicated	O
by	O
the	O
increase	O
in	O
expression	O
of	O
Sod1	B-GP
and	O
Gpx4	B-GP
in	O
Chr16s	O
/	O
s	O
liver	O
.	O

It	O
is	O
likely	O
that	O
the	O
increase	O
in	O
iron	O
and	O
oxidative	O
levels	O
contributed	O
to	O
the	O
upregulation	O
in	O
expression	O
of	O
Hmox1	B-GP
in	O
Chr16s	O
/	O
s	O
liver	O
.	O

Furthermore	O
,	O
there	O
were	O
no	O
differences	O
in	O
gene	O
expression	O
of	O
other	O
iron	O
-	O
related	O
genes	O
in	O
livers	O
and	O
spleen	O
from	O
b	O
/	O
b	O
and	O
s	O
/	O
s	O
mice	B-OG
(	O
Figure	O
3B	O
and	O
Figure	O
S3D	O
).	O

In	O
systemic	O
iron	O
metabolism	O
,	O
intestinal	O
iron	O
absorption	O
can	O
influence	O
hepatic	O
iron	O
content	O
,	O
which	O
reflects	O
whole	O
body	O
iron	O
stores	O
.	O

Thus	O
,	O
we	O
examined	O
the	O
expression	O
of	O
some	O
genes	O
controlling	O
intestinal	O
iron	O
absorption	O
.	O

Western	O
blots	O
showed	O
comparable	O
protein	O
levels	O
of	O
Ferroportin1	B-GP
(	O
Figure	O
3C	O
),	O
the	O
major	O
iron	O
-	O
exporter	O
,	O
in	O
duodenal	O
enterocytes	O
.	O

H	B-GP
-	I-GP
ferritin	I-GP
is	O
required	O
to	O
maintain	O
intestinal	O
iron	O
efflux	O
and	O
H	B-GP
-	I-GP
ferritin	I-GP
deletion	O
in	O
the	O
intestine	O
increases	O
body	O
iron	O
stores	O
and	O
transferrin	B-GP
saturation	O
[	O
24	O
].	O

As	O
our	O
congenic	O
models	O
displayed	O
similar	O
iron	O
-	O
related	O
phenotypes	O
,	O
we	O
tested	O
whether	O
there	O
was	O
an	O
H	B-GP
-	I-GP
ferritin	I-GP
expression	O
difference	O
in	O
the	O
duodenum	O
in	O
Chr16s	O
/	O
s	O
congenics	O
.	O

However	O
,	O
both	O
qPCR	O
and	O
western	O
blot	O
results	O
indicated	O
that	O
there	O
were	O
no	O
differences	O
in	O
H	B-GP
-	I-GP
ferritin	I-GP
expression	O
at	O
the	O
mRNA	O
or	O
protein	O
levels	O
(	O
Figure	O
3C	O
).	O

Additionally	O
,	O
qPCR	O
results	O
showed	O
no	O
significant	O
differences	O
in	O
the	O
expression	O
of	O
selected	O
genes	O
involved	O
in	O
intestinal	O
iron	O
absorption	O
(	O
Figure	O
3D	O
)	O
between	O
Chr16s	O
/	O
s	O
and	O
Chr16b	O
/	O
b	O
groups	O
.	O

Analysis	O
of	O
the	O
candidate	O
genes	O
through	O
genomic	O
DNA	O
sequencing	O
and	O
mRNA	O
expression	O
profiling	O

Iron	O
phenotype	O
analysis	O
of	O
the	O
congenic	O
lines	O
refined	O
the	O
candidate	O
interval	O
of	O
chromosome	O
16	O
to	O
an	O
830	O
kb	O
region	O
(	O
Figure	O
4A	O
).	O

The	O
Ensembl	O
database	O
(	O
Ensembl	O
Genes	O
67	O
)	O
indicated	O
that	O
11	O
candidate	O
genes	O
are	O
located	O
within	O
this	O
critical	O
region	O
(	O
Table	O
S3	O
).	O

None	O
of	O
these	O
candidate	O
genes	O
have	O
previously	O
been	O
reported	O
to	O
have	O
a	O
direct	O
role	O
in	O
iron	O
metabolism	O
.	O

We	O
speculate	O
that	O
the	O
gene	O
(	O
s	O
)	O
underlying	O
this	O
QTL	O
may	O
either	O
have	O
a	O
coding	O
sequence	O
variation	O
that	O
changes	O
the	O
function	O
of	O
the	O
protein	O
or	O
a	O
regulatory	O
sequence	O
variation	O
that	O
could	O
cause	O
differences	O
in	O
gene	O
expression	O
levels	O
between	O
the	O
two	O
parental	O
strains	O
.	O

Exon	O
sequencing	O
all	O
of	O
11	O
genes	O
in	O
the	O
critical	O
interval	O
(	O
Figure	O
4B	O
)	O
identified	O
27	O
SNPs	O
across	O
four	O
genes	O
(	O
Table	O
1	O
).	O

Among	O
these	O
,	O
three	O
genes	O
have	O
coding	O
sequence	O
changes	O
:	O
Sidt1	B-GP
(	O
P172R	O
),	O
Spice1	B-GP
(	O
R708S	O
),	O
Boc	B-GP
(	O
Q1051R	O
and	O
S450	O
-	O
insertion	O
in	O
B6	O
allele	O
).	O

Fine	O
mapping	O
of	O
the	O
QTL	O
on	O
Chr16	O
and	O
candidate	O
genes	O
in	O
the	O
critical	O
interval	O
.	O

(	O
A	O
)	O
Refinement	O
of	O
the	O
Chr16	O
QTL	O
location	O
using	O
sublines	O
.	O

Genotyping	O
markers	O
defining	O
the	O
boundaries	O
are	O
indicated	O
across	O
the	O
top	O
.	O

The	O
black	O
portion	O
of	O
the	O
lines	O
indicates	O
homozygosity	O
for	O
SWR	O
alleles	O
while	O
grey	O
indicates	O
the	O
B6	O
background	O
.	O

Liver	O
iron	O
status	O
was	O
grouped	O
as	O
normal	O
(	O
less	O
than	O
55	O
mg	O
/	O
g	O
)	O
or	O
high	O
(	O
higher	O
than	O
70	O
mg	O
/	O
g	O
)	O
by	O
an	O
arbitrary	O
cut	O
-	O
off	O
and	O
is	O
shown	O
on	O
the	O
right	O
of	O
each	O
panel	O
.	O

(	O
B	O
)	O
The	O
critical	O
candidate	O
region	O
was	O
localized	O
to	O
an	O
840	O
kb	O
region	O
as	O
indicated	O
by	O
the	O
vertical	O
arrow	O
.	O

Arrows	O
indicate	O
the	O
direction	O
of	O
transcription	O
.	O

(	O
C	O
)	O
Haplotype	O
panel	O
of	O
inbred	O
mouse	B-OG
strains	O
for	O
the	O
four	O
non	O
-	O
synonymous	O
SNPs	O
.	O

Genotypes	O
of	O
SNPs	O
were	O
ascertained	O
by	O
direct	O
DNA	O
sequence	O
analysis	O
.	O

Alleles	O
identical	O
to	O
B6	O
alleles	O
are	O
shown	O
in	O
grey	O
and	O
alleles	O
identical	O
to	O
SWR	O
alleles	O
are	O
shown	O
in	O
black	O
.	O

(	O
D	O
)	O
Relative	O
mRNA	O
expression	O
of	O
candidate	O
genes	O
in	O
Chr16	O
congenic	O
mouse	B-OG
liver	O
.	O

Expression	O
of	O
candidate	O
genes	O
is	O
reported	O
as	O
relative	O
expression	O
levels	O
using	O
β	B-GP
-	I-GP
actin	I-GP
as	O
an	O
internal	O
control	O
in	O
each	O
group	O
.	O

The	O
Chr16s	O
/	O
s	O
:	O
Chr16b	O
/	O
b	O
ratios	O
indicate	O
relative	O
expression	O
levels	O
of	O
the	O
Chr16s	O
/	O
s	O
group	O
normalized	O
to	O
the	O
Chr16s	O
/	O
s	O
group	O
,	O
which	O
was	O
defined	O
as	O
1	O
.	O
0	O
.	O

We	O
evaluated	O
the	O
conservation	O
of	O
these	O
four	O
non	O
-	O
synonymous	O
variations	O
by	O
exon	O
sequencing	O
between	O
mouse	B-OG
strains	O
that	O
exhibited	O
differing	O
liver	O
iron	O
statuses	O
.	O

All	O
of	O
the	O
four	O
variations	O
showed	O
consistently	O
different	O
haplotypes	O
between	O
low	O
liver	O
iron	O
strains	O
(	O
C57BL	O
/	O
6J	O
and	O
C57BL	O
/	O
10J	O
[	O
10	O
])	O
and	O
high	O
liver	O
iron	O
strains	O
(	O
FVB	O
/	O
J	O
,	O
DBA	O
/	O
2J	O
and	O
Blab	O
/	O
cJ	O
)	O
(	O
Figure	O
4C	O
).	O

Boc	B-GP
has	O
an	O
insertion	O
of	O
a	O
Ser	O
residue	O
in	O
C57BL	O
strains	O
that	O
makes	O
it	O
different	O
from	O
all	O
other	O
mouse	B-OG
strains	O
and	O
species	O
tested	O
.	O

Moreover	O
,	O
Boc	B-GP
also	O
contained	O
a	O
Q1051R	O
variation	O
,	O
which	O
is	O
conserved	O
in	O
some	O
other	O
mammalian	O
species	O
(	O
Figure	O
S4A	O
,	O
S4B	O
).	O

The	O
P172R	O
amino	O
acid	O
substitution	O
in	O
Sidt1	B-GP
is	O
unique	O
to	O
C57BL	O
strains	O
,	O
altering	O
a	O
residue	O
that	O
is	O
conserved	O
between	O
mouse	B-OG
strains	O
and	O
primates	B-OG
(	O
Figure	O
S4C	O
).	O

While	O
Spice1	B-GP
has	O
an	O
R708S	O
variation	O
at	O
a	O
poorly	O
conserved	O
residue	O
(	O
Figure	O
S4D	O
).	O

To	O
test	O
whether	O
the	O
expression	O
variations	O
of	O
these	O
candidates	O
contributes	O
to	O
the	O
QTL	O
,	O
we	O
examined	O
the	O
expression	O
profile	O
of	O
all	O
11	O
candidates	O
in	O
congenic	O
mouse	B-OG
livers	O
using	O
qPCR	O
.	O

None	O
of	O
the	O
investigated	O
genes	O
exhibited	O
significant	O
differences	O
in	O
their	O
mRNA	O
expression	O
levels	O
in	O
liver	O
,	O
intestine	O
,	O
or	O
spleen	O
in	O
Chr16s	O
/	O
s	O
mice	B-OG
compared	O
with	O
Chr16b	O
/	O
b	O
controls	O
(	O
Figure	O
4D	O
,	O
Figure	O
S5A	O
,	O
S5B	O
).	O

To	O
Further	O
investigate	O
the	O
possible	O
involvement	O
of	O
these	O
candidates	O
in	O
iron	O
metabolism	O
,	O
we	O
performed	O
expression	O
profiling	O
of	O
candidates	O
in	O
livers	O
of	O
mice	B-OG
treated	O
with	O
an	O
iron	O
-	O
rich	O
diet	O
.	O

After	O
mice	B-OG
were	O
fed	O
a	O
high	O
iron	O
diet	O
for	O
1	O
week	O
,	O
we	O
detected	O
a	O
10	O
-	O
fold	O
upregulation	O
of	O
hepatic	O
non	O
-	O
heme	O
iron	O
content	O
(	O
data	O
not	O
shown	O
)	O
and	O
significant	O
decrease	O
in	O
TfR1	B-GP
expression	O
.	O

We	O
found	O
a	O
significant	O
increase	O
in	O
expression	O
of	O
Naa50	B-GP
and	O
Gtpbp8	B-GP
and	O
significant	O
decrease	O
in	O
expression	O
of	O
Zdhhc23	B-GP
in	O
livers	O
of	O
mice	B-OG
with	O
iron	B-DS
overload	I-DS
(	O
Figure	O
S5C	O
).	O

The	O
expression	O
of	O
other	O
candidates	O
was	O
not	O
affected	O
.	O

Overexpression	O
and	O
functional	O
testing	O
of	O
candidates	O
in	O
vivo	O

As	O
expression	O
profiling	O
analysis	O
did	O
not	O
identify	O
a	O
candidate	O
(	O
s	O
)	O
that	O
could	O
be	O
used	O
for	O
a	O
functional	O
study	O
,	O
we	O
aimed	O
to	O
overexpress	O
each	O
candidate	O
in	O
the	O
liver	O
to	O
test	O
their	O
possible	O
function	O
in	O
iron	O
metabolism	O
.	O

Hydrodynamics	O
-	O
based	O
transfection	O
of	O
the	O
liver	O
is	O
a	O
rapid	O
delivery	O
approach	O
with	O
which	O
to	O
study	O
novel	O
gene	O
function	O
in	O
vivo	O
.	O

In	O
fact	O
,	O
this	O
well	O
-	O
established	O
technique	O
has	O
been	O
previously	O
shown	O
not	O
only	O
to	O
successfully	O
deliver	O
expression	O
constructs	O
to	O
the	O
liver	O
with	O
high	O
efficiency	O
,	O
but	O
also	O
to	O
maintain	O
long	O
-	O
term	O
expression	O
of	O
target	O
genes	O
[	O
25	O
].	O

For	O
this	O
purpose	O
,	O
we	O
generated	O
expression	O
constructs	O
of	O
six	O
candidates	O
with	O
previously	O
identified	O
specific	O
biological	O
functions	O
and	O
successfully	O
expressed	O
them	O
in	O
C57BL	B-OG
/	I-OG
6J	I-OG
wild	I-OG
-	I-OG
type	I-OG
mouse	I-OG
liver	O
[	O
26	O
],	O
[	O
27	O
],	O
[	O
28	O
],	O
[	O
29	O
],	O
[	O
30	O
],	O
[	O
31	O
].	O

Six	O
-	O
week	O
-	O
old	O
C57BL	B-OG
/	I-OG
6J	I-OG
mice	I-OG
were	O
injected	O
with	O
30	O
µg	O
of	O
construct	O
DNA	O
via	O
hydrodynamic	O
tail	O
vein	O
injection	O
.	O

Four	O
weeks	O
after	O
injection	O
,	O
the	O
expression	O
of	O
candidates	O
in	O
the	O
liver	O
was	O
confirmed	O
by	O
western	O
blot	O
(	O
Figure	O
5A	O
).	O

We	O
then	O
analyzed	O
the	O
iron	O
phenotype	O
of	O
these	O
mice	B-OG
.	O

None	O
of	O
the	O
six	O
candidates	O
showed	O
the	O
ability	O
to	O
alter	O
hepatic	O
non	O
-	O
heme	O
iron	O
content	O
after	O
successful	O
overexpression	O
in	O
liver	O
(	O
Figure	O
5B	O
).	O

Further	O
,	O
we	O
did	O
not	O
detect	O
a	O
significant	O
change	O
in	O
expression	O
of	O
iron	O
-	O
related	O
genes	O
(	O
Figure	O
S6	O
)	O
or	O
in	O
serum	O
iron	O
or	O
transferrin	B-GP
saturation	O
(	O
data	O
not	O
shown	O
).	O

Overexpression	O
of	O
candidate	O
genes	O
in	O
mouse	B-OG
liver	O
and	O
iron	O
phenotype	O
analysis	O
.	O

Candidate	O
genes	O
were	O
delivered	O
to	O
the	O
mice	B-OG
through	O
hydrodynamic	O
transfection	O
.	O

Four	O
weeks	O
after	O
injection	O
,	O
livers	O
were	O
subjected	O
to	O
analysis	O
(	O
n	O
=	O
5	O
male	O
mice	B-OG
for	O
each	O
group	O
).	O

(	O
A	O
)	O
Overexpression	O
of	O
candidate	O
genes	O
in	O
mouse	B-OG
liver	O
was	O
examined	O
by	O
western	O
blot	O
.	O

Each	O
lane	O
represents	O
an	O
individual	O
mouse	B-OG
in	O
each	O
group	O
.	O

(	O
B	O
)	O
Liver	O
non	O
-	O
heme	O
iron	O
content	O
of	O
each	O
group	O
was	O
examined	O
(	O
n	O
=	O
5	O
male	O
mice	B-OG
for	O
each	O
group	O
).	O

(	O
C	O
)	O
Overexpression	O
of	O
mSidt1	B-GP
-	O
B6	O
and	O
mSidt1	B-GP
-	O
SWR	O
in	O
mouse	B-OG
liver	O
was	O
examined	O
by	O
western	O
blot	O
.	O

(	O
D	O
)	O
Liver	O
non	O
-	O
heme	O
iron	O
content	O
of	O
each	O
group	O
was	O
measured	O
(	O
n	O
=	O
5	O
male	O
mice	B-OG
for	O
each	O
group	O
).	O

(	O
E	O
,	O
F	O
)	O
Analysis	O
of	O
mSidt1	B-GP
(	O
B6	O
and	O
SWR	O
alleles	O
)	O
in	O
an	O
iron	O
uptake	O
assay	O
.	O

HEK	O
293T	O
cells	O
were	O
transiently	O
transfected	O
with	O
empty	O
vector	O
,	O
mSidt1	B-GP
-	O
B6	O
,	O
mSidt1	B-GP
-	O
SWR	O
,	O
and	O
mZip14	B-GP
.	O

48	O
h	O
after	O
transfection	O
,	O
cells	O
were	O
harvested	O
and	O
20	O
ug	O
of	O
protein	O
was	O
used	O
for	O
western	O
blot	O
analysis	O
to	O
verify	O
expression	O
of	O
mSidt1	B-GP
(	O
B6	O
and	O
SWR	O
).	O

Radioactivity	O
was	O
detected	O
by	O
gamma	O
counter	O
and	O
normalized	O
using	O
protein	O
concentrations	O
.	O

Similar	O
results	O
were	O
obtained	O
in	O
three	O
independent	O
experiments	O
with	O
triplicates	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
.	O

N	O
.	O
S	O
:	O
no	O
significance	O
,	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
.	O

Among	O
the	O
candidates	O
,	O
Sidt1	B-GP
encodes	O
a	O
mouse	B-OG
gene	O
homologous	O
with	O
Systemic	B-GP
RNAi	I-GP
Deficient	I-GP
-	I-GP
1	I-GP
in	O
C	B-OG
.	I-OG
elegans	I-OG
,	O
a	O
multi	O
-	O
span	O
transmembrane	B-GP
protein	I-GP
necessary	O
for	O
systemic	O
RNAi	O
activity	O
[	O
32	O
].	O

A	O
recent	O
study	O
identified	O
Sidt1	B-GP
as	O
an	O
active	O
dsRNA	O
-	O
gated	O
dsRNA	O
channel	O
[	O
33	O
].	O

In	O
mice	B-OG
,	O
Sidt1	B-GP
protein	O
is	O
located	O
on	O
hepatocyte	O
plasma	O
membranes	O
[	O
34	O
].	O

Furthermore	O
,	O
sequence	O
analysis	O
and	O
biochemical	O
experiments	O
suggest	O
that	O
Sidt1	B-GP
proteins	O
are	O
composed	O
of	O
an	O
N	O
-	O
terminal	O
extracellular	O
domain	O
followed	O
by	O
9	O
–	O
12	O
predicted	O
transmembrane	O
regions	O
,	O
and	O
that	O
the	O
extracellular	O
domain	O
controls	O
its	O
intrinsic	O
ability	O
to	O
transport	O
dsRNA	O
[	O
35	O
].	O

The	O
P172R	O
variation	O
detected	O
between	O
B6	O
and	O
SWR	B-OG
mice	I-OG
is	O
located	O
in	O
the	O
extracellular	O
N	O
-	O
terminus	O
of	O
mSidt1	B-GP
.	O

We	O
speculated	O
that	O
this	O
variation	O
may	O
affect	O
protein	O
function	O
and	O
thus	O
selected	O
Sidt1	B-GP
as	O
a	O
strong	O
candidate	O
for	O
this	O
study	O
.	O

Hydrodynamics	O
-	O
based	O
transfection	O
was	O
used	O
to	O
test	O
the	O
function	O
of	O
mSidt1	B-GP
(	O
B6	O
and	O
SWR	O
alleles	O
)	O
in	O
the	O
mouse	B-OG
liver	O
.	O

However	O
,	O
after	O
successful	O
overexpression	O
of	O
the	O
two	O
proteins	O
in	O
mouse	B-OG
liver	O
(	O
Figure	O
5C	O
),	O
no	O
significant	O
changes	O
in	O
liver	O
iron	O
were	O
found	O
compared	O
with	O
empty	O
vector	O
controls	O
(	O
Figure	O
5D	O
).	O

We	O
next	O
attempted	O
a	O
cell	O
-	O
based	O
in	O
vitro	O
functional	O
assay	O
to	O
look	O
for	O
evidence	O
of	O
the	O
possible	O
involvement	O
of	O
this	O
molecule	O
in	O
iron	O
metabolism	O
.	O

Bioinformatics	O
predicts	O
that	O
Sidt1	B-GP
may	O
function	O
as	O
a	O
transmembrane	B-GP
cation	I-GP
metal	I-GP
ion	I-GP
transporter	I-GP
[	O
36	O
].	O

We	O
performed	O
a	O
non	O
-	O
transferrin	B-GP
-	O
bound	O
iron	O
(	O
NTBI	O
)	O
uptake	O
assay	O
to	O
test	O
whether	O
mouse	B-OG
Sidt1	B-GP
harbors	O
the	O
ability	O
to	O
function	O
as	O
an	O
iron	B-GP
transporter	I-GP
.	O

HEK	O
293T	O
cells	O
were	O
transiently	O
transfected	O
with	O
mSidt1	B-GP
-	O
B6	O
,	O
mSidt1	B-GP
-	O
SWR	O
,	O
mZip14	B-GP
,	O
or	O
empty	O
vector	O
.	O

Western	O
blot	O
analysis	O
revealed	O
successful	O
expression	O
of	O
Sidt1	B-GP
protein	O
(	O
Figure	O
5E	O
).	O

However	O
,	O
overexpression	O
of	O
mSidt1	B-GP
(	O
both	O
B6	O
allele	O
and	O
SWR	O
allele	O
)	O
did	O
not	O
increase	O
the	O
uptake	O
of	O
NTBI	O
(	O
Figure	O
5F	O
)	O
at	O
different	O
pH	O
values	O
.	O

In	O
all	O
assays	O
,	O
mZip14	B-GP
was	O
included	O
as	O
a	O
positive	O
control	O
[	O
18	O
].	O

Moreover	O
,	O
a	O
transferrin	B-GP
-	O
bound	O
iron	O
(	O
TBI	O
)	O
uptake	O
assay	O
showed	O
that	O
mSidt1	B-GP
did	O
not	O
mediate	O
TBI	O
uptake	O
either	O
(	O
data	O
not	O
shown	O
).	O

Thus	O
,	O
we	O
conclude	O
that	O
mSidt1	B-GP
does	O
not	O
directly	O
mediate	O
iron	O
uptake	O
into	O
cells	O
.	O

Discussion	O

For	O
studies	O
of	O
susceptibility	O
and	O
phenotypic	O
variations	O
in	O
many	O
diseases	O
,	O
characterization	O
of	O
the	O
genetic	O
architecture	O
and	O
identification	O
of	O
the	O
genes	O
that	O
act	O
as	O
modifiers	O
of	O
complex	O
traits	O
are	O
important	O
,	O
but	O
difficult	O
,	O
studies	O
.	O

Systemic	O
iron	O
homeostasis	O
is	O
a	O
complex	O
trait	O
influenced	O
by	O
multiple	O
genetic	O
factors	O
.	O

QTL	O
mapping	O
accompanied	O
by	O
positional	O
cloning	O
has	O
been	O
used	O
previously	O
to	O
identify	O
novel	O
genes	O
involved	O
in	O
iron	O
homeostasis	O
.	O

In	O
fact	O
,	O
many	O
putative	O
QTLs	O
have	O
been	O
identified	O
by	O
classic	O
intercrosses	O
of	O
different	O
mouse	B-OG
strains	O
with	O
varied	O
iron	O
statuses	O
[	O
12	O
],	O
[	O
13	O
],	O
[	O
14	O
].	O

However	O
,	O
it	O
is	O
believed	O
that	O
the	O
true	O
number	O
of	O
QTLs	O
is	O
smaller	O
than	O
reported	O
[	O
37	O
]	O
as	O
few	O
have	O
been	O
validated	O
or	O
fine	O
-	O
mapped	O
through	O
use	O
of	O
congenic	O
mouse	B-OG
models	O
.	O

In	O
our	O
study	O
,	O
we	O
provided	O
evidence	O
to	O
verify	O
the	O
QTL	O
previously	O
identified	O
on	O
Chr16	O
,	O
which	O
is	O
responsible	O
for	O
the	O
difference	O
in	O
basal	O
hepatic	O
iron	O
levels	O
between	O
B6	O
and	O
SWR	B-OG
mice	I-OG
.	O

The	O
QTL	O
was	O
then	O
refined	O
from	O
a	O
20	O
Mb	O
interval	O
down	O
to	O
a	O
0	O
.	O
8	O
Mb	O
interval	O
containing	O
only	O
11	O
genes	O
.	O

Although	O
we	O
failed	O
to	O
verify	O
any	O
candidate	O
genes	O
specifically	O
involved	O
in	O
systemic	O
iron	O
homeostasis	O
,	O
our	O
study	O
still	O
represents	O
a	O
step	O
forward	O
in	O
positional	O
cloning	O
of	O
this	O
QTL	O
and	O
provides	O
a	O
foundation	O
for	O
further	O
identification	O
of	O
the	O
novel	O
functions	O
of	O
these	O
genes	O
in	O
iron	O
metabolism	O
.	O

We	O
first	O
investigated	O
these	O
candidates	O
using	O
genomic	O
DNA	O
sequencing	O
and	O
mRNA	O
expression	O
profiles	O
.	O

We	O
then	O
performed	O
an	O
unbiased	O
functional	O
screen	O
on	O
several	O
candidates	O
using	O
hydrodynamic	O
-	O
based	O
overexpression	O
in	O
the	O
liver	O
.	O

While	O
the	O
overexpression	O
of	O
candidate	O
genes	O
was	O
successful	O
,	O
none	O
of	O
the	O
seven	O
candidates	O
tested	O
altered	O
liver	O
iron	O
status	O
.	O

This	O
method	O
is	O
both	O
rapid	O
and	O
relatively	O
high	O
-	O
throughput	O
making	O
it	O
an	O
ideal	O
assay	O
for	O
our	O
study	O
;	O
however	O
,	O
its	O
range	O
is	O
somewhat	O
limited	O
.	O

It	O
is	O
possible	O
that	O
candidate	O
genes	O
may	O
function	O
in	O
organs	O
other	O
than	O
liver	O
to	O
influence	O
liver	O
iron	O
status	O
,	O
considering	O
that	O
both	O
the	O
serum	O
iron	O
and	O
transferrin	B-GP
saturation	O
are	O
high	O
in	O
Chr16s	O
/	O
s	O
congenics	O
.	O

Thus	O
,	O
liver	O
-	O
specific	O
overexpression	O
of	O
the	O
candidates	O
may	O
not	O
reveal	O
function	O
.	O

The	O
knockout	O
mouse	B-OG
approach	O
may	O
prove	O
to	O
be	O
a	O
better	O
strategy	O
by	O
which	O
to	O
study	O
these	O
candidate	O
genes	O
,	O
and	O
we	O
plan	O
to	O
employ	O
this	O
tactic	O
in	O
future	O
studies	O
.	O

In	O
some	O
cases	O
,	O
QTLs	O
may	O
result	O
from	O
several	O
polymorphisms	O
residing	O
in	O
one	O
gene	O
or	O
closely	O
linked	O
genes	O
rather	O
than	O
a	O
single	O
genetic	O
variation	O
[	O
38	O
],	O
[	O
39	O
],	O
[	O
40	O
].	O

In	O
our	O
study	O
,	O
we	O
have	O
identified	O
a	O
total	O
of	O
27	O
polymorphisms	O
in	O
four	O
candidates	O
(	O
Table	O
1	O
).	O

However	O
,	O
it	O
would	O
be	O
prohibitively	O
laborious	O
to	O
perform	O
functional	O
tests	O
on	O
each	O
candidate	O
variation	O
as	O
well	O
as	O
their	O
different	O
combinations	O
.	O

Among	O
the	O
candidate	O
genes	O
,	O
three	O
have	O
non	O
-	O
synonymous	O
coding	O
sequence	O
variations	O
.	O
Sidt1	B-GP
has	O
a	O
conserved	O
P172R	O
variation	O
represented	O
in	O
C57BL	O
strains	O
(	O
Pro	O
).	O

Previous	O
studies	O
indicated	O
that	O
Sidt1	B-GP
functions	O
as	O
an	O
active	O
dsRNA	O
channel	O
[	O
34	O
]	O
and	O
bioinformatics	O
analysis	O
suggested	O
that	O
Sidt1	B-GP
may	O
possess	O
iron	O
transporter	O
activity	O
[	O
41	O
].	O

Thus	O
,	O
we	O
selected	O
Sidt1	B-GP
for	O
our	O
first	O
functional	O
study	O
.	O

Two	O
forms	O
of	O
Sidt1	B-GP
(	O
B6	O
and	O
SWR	O
alleles	O
)	O
were	O
overexpressed	O
in	O
liver	O
but	O
failed	O
to	O
change	O
hepatic	O
iron	O
content	O
.	O

A	O
cell	O
transfection	O
assay	O
also	O
ruled	O
out	O
the	O
possibility	O
that	O
mouse	B-OG
Sidt1	B-GP
acts	O
as	O
a	O
direct	O
NTBI	B-GP
transporter	I-GP
.	O

However	O
,	O
it	O
is	O
possible	O
that	O
Sidt1	B-GP
could	O
uptake	O
some	O
other	O
solutes	O
and	O
in	O
turn	O
,	O
affect	O
iron	O
homeostasis	O
.	O

Future	O
studies	O
will	O
be	O
required	O
to	O
assess	O
this	O
possibility	O
.	O

Boc	B-GP
has	O
two	O
non	O
-	O
synonymous	O
variations	O
,	O
with	O
the	O
Ser450	O
insertion	O
variation	O
being	O
highly	O
conserved	O
between	O
mouse	B-OG
strains	O
and	O
other	O
species	O
making	O
it	O
a	O
relatively	O
strong	O
candidate	O
.	O

However	O
,	O
Boc	B-GP
gene	O
expression	O
in	O
the	O
liver	O
is	O
low	O
and	O
its	O
only	O
reported	O
function	O
is	O
during	O
neural	O
development	O
[	O
26	O
],	O
[	O
42	O
].	O

Considering	O
this	O
,	O
overexpression	O
of	O
Boc	B-GP
in	O
the	O
liver	O
may	O
not	O
fully	O
reflect	O
its	O
role	O
in	O
vivo	O
.	O

The	O
available	O
Boc	B-GP
knockout	O
mouse	B-OG
model	O
should	O
provide	O
a	O
superior	O
method	O
with	O
which	O
to	O
assess	O
Boc	B-GP
'	O
s	O
possible	O
role	O
in	O
iron	O
metabolism	O
[	O
26	O
].	O
Spice1	B-GP
also	O
has	O
a	O
non	O
-	O
synonymous	O
variation	O
.	O

However	O
,	O
as	O
a	O
novel	O
gene	O
without	O
validated	O
in	O
vivo	O
functions	O
,	O
it	O
is	O
hard	O
to	O
predict	O
its	O
possible	O
role	O
or	O
mechanism	O
of	O
action	O
in	O
iron	O
metabolism	O
.	O

Among	O
the	O
candidates	O
genes	O
,	O
Atp6v1a	B-GP
is	O
reported	O
to	O
be	O
involved	O
in	O
iron	O
metabolism	O
.	O
Atp6v1a	B-GP
,	O
ATPase	B-GP
H	I-GP
+	I-GP
transporting	I-GP
lysosomal	I-GP
V1	I-GP
subunit	I-GP
A	I-GP
,	O
belongs	O
to	O
the	O
V	B-GP
-	I-GP
type	I-GP
ATPase	I-GP
protein	O
family	O
.	O

This	O
protein	O
complex	O
is	O
responsible	O
for	O
pumping	O
protons	O
from	O
the	O
cytoplasm	O
to	O
the	O
lumen	O
of	O
organelles	O
and	O
plays	O
important	O
roles	O
in	O
endosomal	O
acidification	O
,	O
which	O
is	O
important	O
for	O
the	O
endocytic	O
pathway	O
[	O
28	O
].	O

V	B-GP
-	I-GP
type	I-GP
ATPase	I-GP
inhibitors	O
have	O
been	O
shown	O
to	O
affect	O
transferrin	B-GP
recycling	O
and	O
iron	O
uptake	O
[	O
43	O
],	O
[	O
44	O
].	O

Additionally	O
,	O
Nieland	O
,	O
et	O
al	O
.	O
found	O
two	O
sulfonamide	O
compounds	O
that	O
could	O
reversibly	O
inhibit	O
transferrin	B-GP
-	O
mediated	O
iron	O
uptake	O
through	O
alteration	O
of	O
endosomal	O
and	O
lysosomal	O
pH	O
by	O
inhibiting	O
V	B-GP
-	I-GP
ATPase	I-GP
'	O
s	O
ATP	O
hydrolysis	O
activity	O
[	O
45	O
].	O

The	O
zebrafish	B-OG
(	O
Danio	B-OG
rerio	I-OG
)	O
orthologue	O
of	O
Atp6v1a	B-GP
has	O
a	O
critical	O
role	O
in	O
embryonic	O
acid	O
secretion	O
and	O
ion	O
balance	O
[	O
46	O
].	O

Together	O
these	O
findings	O
strongly	O
implicate	O
Atp6v1a	B-GP
in	O
iron	O
metabolism	O
;	O
however	O
,	O
we	O
did	O
not	O
find	O
any	O
coding	O
sequence	O
variations	O
or	O
expression	O
differences	O
in	O
this	O
gene	O
in	O
our	O
congenic	O
mouse	B-OG
models	O
.	O

Nonetheless	O
,	O
the	O
possibility	O
remains	O
that	O
there	O
are	O
variations	O
in	O
Atp6v1a	B-GP
protein	O
levels	O
,	O
including	O
protein	O
content	O
and	O
subcellular	O
localization	O
,	O
in	O
our	O
models	O
.	O

Further	O
studies	O
are	O
necessary	O
for	O
detailed	O
investigation	O
of	O
Atp6v1a	B-GP
'	O
s	O
role	O
in	O
iron	O
metabolism	O
.	O

Using	O
the	O
iron	O
rich	O
diet	O
-	O
treated	O
mouse	B-OG
model	O
,	O
we	O
detected	O
3	O
genes	O
(	O
Zdhhc23	B-GP
,	O
Naa50	B-GP
and	O
Gtpbp8	B-GP
)	O
with	O
changes	O
in	O
expression	O
induced	O
by	O
severe	O
hepatic	O
iron	B-DS
overload	I-DS
.	O

Among	O
these	O
genes	O
,	O
Zdhhc23	B-GP
(	O
zinc	B-GP
finger	I-GP
,	I-GP
DHHC	I-GP
domain	I-GP
containing	I-GP
23	I-GP
)	O
is	O
a	O
palmitoyl	B-GP
-	I-GP
transferase	I-GP
involved	O
in	O
protein	O
palmitoylation	O
.	O
Zdhhc23	B-GP
is	O
reported	O
to	O
control	O
the	O
palmitoylation	O
of	O
calcium	B-GP
-	I-GP
activated	I-GP
potassium	I-GP
channels	I-GP
,	O
which	O
is	O
important	O
for	O
the	O
surface	O
expression	O
of	O
these	O
ion	B-GP
channels	I-GP
[	O
27	O
].	O

Also	O
,	O
palmitoylation	O
is	O
important	O
for	O
cell	O
-	O
surface	O
expression	O
,	O
spatial	O
organization	O
,	O
and	O
activity	O
of	O
many	O
other	O
ion	B-GP
channels	I-GP
[	O
47	O
].	O

The	O
decreased	O
expression	O
of	O
Zdhhc23	B-GP
in	O
iron	B-DS
overload	I-DS
liver	O
may	O
represent	O
a	O
response	O
to	O
iron	O
accumulation	O
by	O
regulation	O
of	O
the	O
activities	O
of	O
ion	B-GP
channels	I-GP
that	O
could	O
potentially	O
be	O
responsible	O
for	O
iron	O
metabolism	O
.	O

Whether	O
these	O
genes	O
are	O
involved	O
in	O
iron	O
metabolism	O
will	O
require	O
further	O
study	O
.	O

Hemochromatosis	B-DS
is	O
a	O
typical	O
iron	B-DS
-	I-DS
related	I-DS
disorder	I-DS
characterized	O
by	O
excessive	O
iron	B-DS
-	I-DS
overload	I-DS
in	O
the	O
liver	O
and	O
other	O
parenchymal	O
organs	O
.	O

Genetic	O
mutations	O
affecting	O
hamp1	B-GP
expression	O
or	O
the	O
hepcidin	B-GP
-	O
Ferroportin1	B-GP
axis	O
can	O
cause	O
this	O
syndrome	O
.	O

In	O
our	O
congenic	O
models	O
,	O
we	O
found	O
that	O
the	O
expression	O
of	O
hamp1	B-GP
is	O
normal	O
and	O
the	O
signaling	O
pathways	O
controlling	O
hepcidin	B-GP
expression	O
examined	O
(	O
BMP	B-GP
-	O
HJV	B-GP
,	O
TfR2	B-GP
-	O
HFE	B-GP
,	O
and	O
inflammation	O
pathways	O
)	O
are	O
intact	O
.	O

We	O
also	O
did	O
not	O
find	O
gene	O
expression	O
changes	O
in	O
Fpn1	B-GP
.	O

Thus	O
,	O
we	O
inferred	O
that	O
the	O
candidate	O
modifier	O
(	O
s	O
)	O
may	O
affect	O
liver	O
iron	O
homeostasis	O
through	O
pathways	O
other	O
than	O
hepcidin	B-GP
regulation	O
.	O

We	O
found	O
a	O
significant	O
increase	O
in	O
both	O
liver	O
and	O
serum	O
iron	O
levels	O
in	O
Chr16s	O
/	O
s	O
congenics	O
,	O
which	O
implied	O
co	O
-	O
upregulation	O
of	O
these	O
traits	O
by	O
the	O
candidate	O
genes	O
[	O
37	O
].	O

Moreover	O
,	O
this	O
indicated	O
the	O
causal	O
link	O
between	O
upregulation	O
of	O
intestinal	O
iron	O
absorption	O
and	O
elevated	O
hepatic	O
iron	O
content	O
.	O

Although	O
we	O
did	O
not	O
find	O
significant	O
changes	O
in	O
the	O
expression	O
levels	O
of	O
genes	O
involved	O
in	O
iron	O
absorption	O
(	O
DMT	B-GP
-	I-GP
1	I-GP
,	O
Dcytb	B-GP
,	O
Hephestin	B-GP
,	O
Ferroportin1	B-GP
and	O
H	B-GP
-	I-GP
Ferritin	I-GP
)	O
between	O
Chr16s	O
/	O
s	O
congenics	O
and	O
Chr16b	O
/	O
b	O
controls	O
,	O
we	O
still	O
could	O
not	O
rule	O
out	O
the	O
possibility	O
that	O
changes	O
in	O
intestinal	O
iron	O
absorption	O
may	O
partially	O
contribute	O
to	O
the	O
elevated	O
hepatic	O
iron	O
accumulation	O
.	O

More	O
comprehensive	O
approaches	O
including	O
intestinal	O
radioactive	O
iron	O
absorption	O
assays	O
are	O
needed	O
to	O
fully	O
investigate	O
this	O
possibility	O
.	O

Mouse	B-OG
heme	B-GP
oxygenase	I-GP
1	I-GP
(	O
Hmox1	B-GP
)	O
catabolizes	O
cellular	O
heme	O
to	O
biliverdin	O
,	O
carbon	O
monoxide	O
,	O
and	O
free	O
iron	O
[	O
48	O
].	O

This	O
process	O
is	O
crucial	O
for	O
the	O
expulsion	O
of	O
iron	O
from	O
tissue	O
stores	O
.	O
Hmox1	B-GP
KO	O
mice	B-OG
showed	O
low	O
serum	O
iron	O
and	O
anemia	B-DS
while	O
they	O
had	O
mild	O
iron	O
loading	O
in	O
liver	O
and	O
kidney	O
at	O
50	O
weeks	O
of	O
age	O
[	O
49	O
].	O
Hmox1	B-GP
expression	O
is	O
regulated	O
by	O
heme	O
,	O
iron	O
,	O
oxidative	O
stress	O
and	O
inflammatory	O
stimuli	O
[	O
22	O
].	O

In	O
our	O
model	O
,	O
we	O
concluded	O
that	O
the	O
upregulation	O
of	O
Hmox1	B-GP
expression	O
in	O
congenic	O
liver	O
is	O
induced	O
by	O
elevated	O
iron	O
and	O
heme	O
content	O
and	O
oxidative	O
stress	O
level	O
.	O

The	O
differences	O
in	O
hepatic	O
iron	O
status	O
in	O
these	O
mice	B-OG
could	O
contribute	O
to	O
predisposition	O
to	O
iron	B-DS
-	I-DS
related	I-DS
disorders	I-DS
.	O

SWR	B-OG
mouse	I-OG
strains	O
are	O
more	O
susceptible	O
to	O
uroporphyria	B-DS
[	O
11	O
]	O
and	O
are	O
more	O
resistant	O
to	O
hepatic	O
protoporphyria	B-DS
[	O
50	O
],	O
which	O
are	O
caused	O
by	O
some	O
iron	O
-	O
chelating	O
drugs	O
.	O

In	O
our	O
congenic	O
model	O
,	O
the	O
differences	O
in	O
hepatic	O
iron	O
levels	O
could	O
not	O
be	O
explained	O
by	O
variations	O
in	O
known	O
iron	O
-	O
related	O
genes	O
and	O
thus	O
,	O
the	O
novel	O
modifier	O
identified	O
in	O
this	O
region	O
may	O
confer	O
predisposition	O
to	O
these	O
iron	B-DS
-	I-DS
related	I-DS
disorders	I-DS
in	O
different	O
mouse	B-OG
strains	O
.	O

In	O
summary	O
,	O
we	O
validated	O
and	O
fine	O
-	O
mapped	O
the	O
QTL	O
on	O
Chr16	O
controlling	O
hepatic	O
iron	O
accumulation	O
.	O

Using	O
sequencing	O
data	O
and	O
expression	O
profile	O
analyses	O
,	O
we	O
identified	O
three	O
strong	O
candidates	O
,	O
Sidt1	B-GP
,	O
Boc	B-GP
,	O
and	O
Spice1	B-GP
,	O
which	O
had	O
non	O
-	O
synonymous	O
variations	O
.	O

This	O
study	O
could	O
guide	O
future	O
work	O
for	O
identification	O
of	O
a	O
novel	O
genetic	O
modifier	O
involved	O
in	O
iron	O
metabolism	O
.	O

Supporting	O
Information	O

Measurements	O
of	O
non	O
-	O
heme	O
iron	O
content	O
of	O
organs	O
including	O
heart	O
,	O
kidney	O
,	O
lung	O
,	O
and	O
pancreas	O
of	O
original	O
Chr16	O
congenic	O
mice	B-OG
(	O
n	O
>	O
=	O
5	O
for	O
each	O
group	O
,	O
8	O
weeks	O
).	O
Data	O
represent	O
mean	O
±	O
SEM	O
,	O
N	O
.	O
S	O
:	O
no	O
significance	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Measurement	O
of	O
liver	O
and	O
spleen	O
non	O
-	O
heme	O
iron	O
contents	O
of	O
congenic	O
line	O
5	O
,	O
line	O
6	O
,	O
and	O
line	O
7	O
.	O
Data	O
represent	O
mean	O
±	O
SEM	O
,	O
N	O
.	O
S	O
:	O
no	O
significance	O
,	O
n	O
=	O
5	O
for	O
each	O
group	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

(	O
A	O
)	O
Measurement	O
of	O
liver	O
heme	O
iron	O
contents	O
of	O
Chr16	O
congenic	O
line	O
3	O
.	O

(	O
B	O
)	O
Relative	O
mRNA	O
expression	O
of	O
Fth1	B-GP
,	O
Sod1	B-GP
and	O
Gpx4	B-GP
in	O
congenic	O
mouse	B-OG
liver	O
.	O

(	O
C	O
)	O
Relative	O
mRNA	O
expression	O
of	O
IL	B-GP
-	I-GP
6	I-GP
,	O
TNF	B-GP
-	I-GP
α	I-GP
and	O
IL	B-GP
-	I-GP
1β	I-GP
in	O
Chr16	O
congenic	O
mouse	B-OG
liver	O
and	O
spleen	O
.	O

(	O
D	O
)	O
Relative	O
mRNA	O
levels	O
of	O
Fpn1	B-GP
and	O
TfR1	B-GP
in	O
congenic	O
spleen	O
.	O

Expression	O
of	O
indicated	O
genes	O
is	O
reported	O
as	O
relative	O
expression	O
levels	O
using	O
β	B-GP
-	I-GP
actin	I-GP
as	O
an	O
internal	O
control	O
in	O
each	O
group	O
.	O

The	O
Chr16s	O
/	O
s	O
:	O
Chr16b	O
/	O
b	O
ratios	O
indicate	O
relative	O
expression	O
levels	O
of	O
the	O
Chr16s	O
/	O
s	O
group	O
normalized	O
to	O
the	O
Chr16s	O
/	O
s	O
group	O
,	O
which	O
was	O
defined	O
as	O
1	O
.	O
0	O
.	O
n	O
>	O
5	O
for	O
each	O
group	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
,	O
N	O
.	O
S	O
:	O
no	O
significance	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Conservation	O
of	O
the	O
non	O
-	O
synonymous	O
variations	O
detected	O
in	O
genes	O
Boc	B-GP
,	O
Sidt1	B-GP
,	O
and	O
Spice1	B-GP
across	O
species	O
.	O
The	O
position	O
of	O
each	O
fragment	O
is	O
indicated	O
by	O
the	O
numbers	O
on	O
the	O
right	O
and	O
sources	O
of	O
sequences	O
are	O
shown	O
on	O
the	O
left	O
.	O

The	O
alignments	O
were	O
performed	O
by	O
the	O
Clustal	O
W	O
Method	O
.	O

The	O
black	O
shading	O
indicates	O
residues	O
that	O
match	O
the	O
consensus	O
.(	O
A	O
)	O
Boc	B-GP
of	O
C57BL	O
alleles	O
has	O
unique	O
Ser450	O
insertions	O
,	O
a	O
polymorphism	O
not	O
previously	O
reported	O
.	O

(	O
B	O
)	O
Boc	B-GP
also	O
has	O
a	O
Q1051R	O
variation	O
at	O
a	O
conserved	O
residue	O
.	O

(	O
C	O
)	O
Sidt1	B-GP
has	O
a	O
P172R	O
variation	O
and	O
the	O
residue	O
is	O
conserved	O
between	O
humans	B-OG
and	O
rodents	B-OG
.	O

(	O
D	O
)	O
Spice1	B-GP
shows	O
an	O
R708S	O
variation	O
at	O
a	O
poorly	O
conserved	O
residue	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Relative	O
mRNA	O
expression	O
of	O
candidate	O
genes	O
in	O
Chr16	O
congenic	O
mouse	B-OG
intestine	O
(	O
A	O
)	O
and	O
spleen	O
(	O
B	O
).	O
The	O
Chr16s	O
/	O
s	O
:	O
Chr16b	O
/	O
b	O
ratios	O
indicate	O
relative	O
expression	O
levels	O
of	O
the	O
Chr16s	O
/	O
s	O
group	O
normalized	O
to	O
the	O
Chr16s	O
/	O
s	O
group	O
,	O
which	O
was	O
defined	O
as	O
1	O
.	O
0	O
.	O

(	O
C	O
)	O
Relative	O
mRNA	O
expression	O
of	O
candidate	O
genes	O
in	O
mice	B-OG
liver	O
treated	O
with	O
iron	O
rich	O
diet	O
.	O

The	O
ratios	O
represent	O
the	O
relative	O
expression	O
values	O
normalized	O
to	O
control	O
group	O
,	O
which	O
was	O
defined	O
as	O
1	O
.	O
0	O
.	O
β	B-GP
-	I-GP
actin	I-GP
was	O
as	O
an	O
internal	O
control	O
in	O
each	O
group	O
.	O
n	O
>	O
=	O
5	O
for	O
each	O
group	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
,	O
N	O
.	O
S	O
:	O
no	O
significance	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Relative	O
mRNA	O
expression	O
of	O
iron	O
related	O
genes	O
in	O
mouse	B-OG
liver	O
overexpressed	O
the	O
indicated	O
candidate	O
genes	O
through	O
hydrodynamic	O
transfection	O
.	O
n	O
=	O
5	O
male	O
mice	B-OG
for	O
each	O
group	O
,	O
β	B-GP
-	I-GP
actin	I-GP
was	O
used	O
as	O
an	O
internal	O
control	O
and	O
data	O
was	O
represent	O
as	O
ratios	O
of	O
pLIVE	O
control	O
relative	O
to	O
candidate	O
genes	O
group	O
.	O

Data	O
represent	O
mean	O
±	O
SEM	O
,	O
N	O
.	O
S	O
:	O
no	O
significance	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Sequences	O
of	O
genotyping	O
primers	O
.	O

(	O
DOCX	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Sequences	O
of	O
oligonucleotide	O
primers	O
for	O
Real	O
-	O
time	O
PCR	O
.	O

(	O
DOCX	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Interval	O
candidate	O
gene	O
accession	O
numbers	O
.	O

(	O
DOCX	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

